Abonnement à la biblothèque: Guest
Critical Reviews™ in Oncogenesis

Publication de 4  numéros par an

ISSN Imprimer: 0893-9675

ISSN En ligne: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Immunological Cells and Functions in Gaucher Disease

Volume 18, Numéro 3, 2013, pp. 197-220
DOI: 10.1615/CritRevOncog.2013004503
Get accessGet access

RÉSUMÉ

The macrophage (MΦ) has been the focus of causality, research, and therapy of Gaucher disease, but recent evidence casts doubt its solitary role in the disease pathogenesis. The excess of glucosylceramide (GC) in such cells accounts for some of the disease manifestations. Evidence of increased expression of C-C and C-X-C chemokines (i.e., CCL2,CXCL1, CXCL8) in Gaucher disease could be critical for monocyte transformation to inflammatory subsets of macrophages and dendritic cells (DC) as well as neutrophil (PMNs) recruitment to visceral organs. These immune responses could be essential for activation of T- and B-cell subsets, and the induction of numerous cytokines and chemokines that participate in the initiation and propagation of the molecular pathogenesis of Gaucher disease. The association of Gaucher disease with a variety of cellular and humoral immune responses is reviewed here to provide a potential foundation for expanding the complex pathophysiology of Gaucher disease.

CITÉ PAR
  1. Pandey Manoj Kumar, Grabowski Gregory A, Cytology of Gaucher disease, in Gaucher Disease: Basic and Clinical Perspectives, 2013. Crossref

  2. Bettman Noam, Avivi Irit, Rosenbaum Hanna, Bisharat Lina, Katz Tamar, Impaired migration capacity in monocytes derived from patients with Gaucher disease, Blood Cells, Molecules, and Diseases, 55, 2, 2015. Crossref

  3. Zahran Asmaa M., Eltayeb Azza A., Elsayh Khalid I., Saad Khaled, Ahmad Faisal-Alkhateeb, Ibrahim Ahmad I. M., Activated and Memory T Lymphocytes in Children with Gaucher Disease, Archivum Immunologiae et Therapiae Experimentalis, 65, 3, 2017. Crossref

  4. Limgala Renuka Pudi, Ioanou Chidima, Plassmeyer Matthew, Ryherd Mark, Kozhaya Lina, Austin Lauren, Abidoglu Cem, Unutmaz Derya, Alpan Oral, Goker-Alpan Ozlem, Dardis Andrea, Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease, PLOS ONE, 11, 12, 2016. Crossref

  5. Sønder Søren Ulrik, Limgala Renuka Pudi, Ivanova Margarita M., Ioanou Chidima, Plassmeyer Matthew, Marti Gerald E., Alpan Oral, Goker-Alpan Ozlem, Persistent immune alterations and comorbidities in splenectomized patients with Gaucher disease, Blood Cells, Molecules, and Diseases, 59, 2016. Crossref

  6. de Mello Alexandre Silva, da Silva Ivy Reichert Vital, Reinaldo Gustavo Pereira, Dorneles Gilson Pires, Cé Jaqueline, Lago Pedro Dal, Peres Alessandra, Elsner Viviane Rostirola, Coelho Janice Carneiro, The modulation of inflammatory parameters, Brain-derived neurotrophic factor levels and global histone H4 acetylation status in peripheral blood of patients with Gaucher disease type 1, Clinical Biochemistry, 50, 4-5, 2017. Crossref

  7. Ferreira Carlos R., Gahl William A., Lysosomal storage diseases, Translational Science of Rare Diseases, 2, 1-2, 2017. Crossref

  8. Gras-Colomer Elena, Martínez-Gómez María Amparo, Moya-Gil Ana, Fernandez-Zarzoso Miguel, Merino-Sanjuan Matilde, Climente-Martí Mónica, Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment, Clinical Pharmacokinetics, 55, 9, 2016. Crossref

  9. Dworski Shaalee, Lu Ping, Khan Aneal, Maranda Bruno, Mitchell John J., Parini Rossella, Di Rocco Maja, Hugle Boris, Yoshimitsu Makoto, Magnusson Bo, Makay Balahan, Arslan Nur, Guelbert Norberto, Ehlert Karoline, Jarisch Andrea, Gardner-Medwin Janet, Dagher Rawane, Terreri Maria Teresa, Lorenco Charles Marques, Barillas-Arias Lilianna, Tanpaiboon Pranoot, Solyom Alexander, Norris James S., He Xingxuan, Schuchman Edward H., Levade Thierry, Medin Jeffrey A., Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863, 2, 2017. Crossref

  10. Koppe Tiago, Doneda Divair, Siebert Marina, Paskulin Livia, Camargo Matheus, Tirelli Kristiane Michelin, Vairo Filippo, Daudt Liane, Schwartz Ida Vanessa D., The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher disease, Genetics and Molecular Biology, 39, 1, 2016. Crossref

  11. Abu-Asab Mones S., Yeung Ian Y. L., Ardeljan Christopher, Gonzalez Ashley N., Sidransky Ellen, Chan Chi-Chao, Ocular Implications of Gaucher Disease, in Advances in Vision Research, Volume I, 2017. Crossref

  12. Borger Daniel K., McMahon Benjamin, Roshan Lal Tamanna, Serra-Vinardell Jenny, Aflaki Elma, Sidransky Ellen, Induced pluripotent stem cell models of lysosomal storage disorders, Disease Models & Mechanisms, 10, 6, 2017. Crossref

  13. Okamoto Kazuo, Nakashima Tomoki, Shinohara Masahiro, Negishi-Koga Takako, Komatsu Noriko, Terashima Asuka, Sawa Shinichiro, Nitta Takeshi, Takayanagi Hiroshi, Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems, Physiological Reviews, 97, 4, 2017. Crossref

  14. Hannibal Luciana, Siebert Marina, Basgalupp Suélen, Vario Filippo, Spiekerkoetter Ute, Blom Henk J., Hampered Vitamin B12 Metabolism in Gaucher Disease?, Journal of Inborn Errors of Metabolism and Screening, 5, 2017. Crossref

  15. Pandey Manoj K., Burrow Thomas A., Rani Reena, Martin Lisa J., Witte David, Setchell Kenneth D., Mckay Mary A., Magnusen Albert F., Zhang Wujuan, Liou Benjamin, Köhl Jörg, Grabowski Gregory A., Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease, Nature, 543, 7643, 2017. Crossref

  16. Gras-Colomer Elena, Martínez-Gómez María-Amparo, Climente-Martí Mónica, Fernandez-Zarzoso Miguel, Almela-Tejedo Mercedes, Giner-Galvañ Vicente, Marcos-Rodríguez Jose-Antonio, Rodríguez-Fernández Alicia, Torralba-Cabeza Miguel-Ángel, Merino-Sanjuan Matilde, Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I, Basic & Clinical Pharmacology & Toxicology, 123, 1, 2018. Crossref

  17. Muthuraman Arunachalam, Rishitha Narahari, Mehdi Seema, Role of nanoparticles in bioimaging, diagnosis and treatment of cancer disorder, in Design of Nanostructures for Theranostics Applications, 2018. Crossref

  18. Mullin S., Hughes D., Mehta A., Schapira A. H. V., Neurological effects of glucocerebrosidase gene mutations, European Journal of Neurology, 26, 3, 2019. Crossref

  19. Le Peillet Damien, Prendki Virginie, Trombert Véronique, Laffitte Emmanuel, Assal Frédéric, Reny Jean Luc, Serratrice Christine, Type I Gaucher disease with bullous pemphigoid and Parkinson disease, Medicine, 97, 13, 2018. Crossref

  20. Pandey Manoj K., Grabowski Gregory A., Köhl Jörg, An unexpected player in Gaucher disease: The multiple roles of complement in disease development, Seminars in Immunology, 37, 2018. Crossref

  21. Wątek Marzena, Piktel Ewelina, Wollny Tomasz, Durnaś Bonita, Fiedoruk Krzysztof, Lech-Marańda Ewa, Bucki Robert, Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development, International Journal of Molecular Sciences, 20, 4, 2019. Crossref

  22. Ivanova Margarita M., Changsila Erk, Iaonou Chidima, Goker-Alpan Ozlem, Trajkovic Vladimir, Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases, PLOS ONE, 14, 1, 2019. Crossref

  23. Ługowska Agnieszka, Hetmańczyk-Sawicka Katarzyna, Iwanicka-Nowicka Roksana, Fogtman Anna, Cieśla Jarosław, Purzycka-Olewiecka Joanna Karolina, Sitarska Dominika, Płoski Rafał, Filocamo Mirella, Lualdi Susanna, Bednarska-Makaruk Małgorzata, Koblowska Marta, Gene expression profile in patients with Gaucher disease indicates activation of inflammatory processes, Scientific Reports, 9, 1, 2019. Crossref

  24. Dimitriou Evangelia, Paschali Evangelia, Kanariou Maria, Michelakakis Helen, Prevalence of antibodies to ganglioside and Hep 2 in Gaucher, Niemann – Pick type C and Sanfilippo diseases, Molecular Genetics and Metabolism Reports, 20, 2019. Crossref

  25. Zimmermann Nives, Gibbons William J., Homan Shelli M., Prows Daniel R., Heart disease in a mutant mouse model of spontaneous eosinophilic myocarditis maps to three loci, BMC Genomics, 20, 1, 2019. Crossref

  26. Zahran Asmaa M., Youssef Mervat A. M., Shafik Engy Adel, Zahran Zeinab Albadry M., El-Badawy Omnia, Abo Elgheet Amir M., Elsayh Khalid I., Downregulation of B regulatory cells and upregulation of T helper 1 cells in children with Gaucher disease undergoing enzyme replacement therapy, Immunologic Research, 68, 2, 2020. Crossref

  27. Tran Christel, Unger Sheila, Superti-Furga Andrea, Gaucher Disease and Bone Manifestations, in Encyclopedia of Bone Biology, 2020. Crossref

  28. Ganetzky Rebecca D., Goldstein Amy C., Metabolic disorders with immunologic consequences, in Stiehm's Immune Deficiencies, 2020. Crossref

  29. Ivanova Margarita, Altered Sphingolipids Metabolism Damaged Mitochondrial Functions: Lessons Learned From Gaucher and Fabry Diseases, Journal of Clinical Medicine, 9, 4, 2020. Crossref

  30. Limgala Renuka P., Goker-Alpan Ozlem, Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease, Biomolecules, 10, 4, 2020. Crossref

  31. Mistry Pramod, Balwani Manisha, Barbouth Deborah, Burrow T. Andrew, Ginns Edward I., Goker-Alpan Ozlem, Grabowski Gregory A., Kartha Reena V., Kishnani Priya S., Lau Heather, Lee Chung U., Lopez Grisel, Maegawa Gustavo, Packman Seymour, Prada Carlos, Rosenbloom Barry, Lal Tamanna Roshan, Schiffmann Rapheal, Weinreb Neal, Sidransky Ellen, Gaucher disease and SARS-CoV-2 infection: Emerging management challenges, Molecular Genetics and Metabolism, 130, 3, 2020. Crossref

  32. Anderson Hans E., Taylor Matthew R. G., Consequences of treatment for hemophagocytic lymphohistiocytosis in a patient with undiagnosed Gaucher disease Type 1, American Journal of Medical Genetics Part A, 182, 12, 2020. Crossref

  33. Kartha Reena V., Terluk Marcia R., Brown Roland, Travis Abigail, Mishra Usha R., Rudser Kyle, Lau Heather, Jarnes Jeanine R., Cloyd James C., Weinreb Neal J., Patients with Gaucher disease display systemic oxidative stress dependent on therapy status, Molecular Genetics and Metabolism Reports, 25, 2020. Crossref

  34. Chalès G., Guggenbuhl P., Cador-Rousseau B., Cathelineau C., Guillin R., Manifestaciones osteoarticulares de las esfingolipidosis en adultos, EMC - Aparato Locomotor, 53, 4, 2020. Crossref

  35. Bonesteele Grant, Gargus J. Jay, Curtin Emily, Tang Mabel, Rosenbloom Barry, Kimonis Virginia, Diffuse large B-cell non-Hodgkin's lymphoma in Gaucher disease, Molecular Genetics and Metabolism Reports, 25, 2020. Crossref

  36. Massaro Giulia, Hughes Michael P, Whaler Sammie M, Wallom Kerri-Lee, Priestman David A, Platt Frances M, Waddington Simon N, Rahim Ahad A, Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes, Human Molecular Genetics, 29, 12, 2020. Crossref

  37. Verkuil F., Bosch A. M., Struijs P. A. A., Hemke R., van den Berg J. M., Inflammatory arthritis complicating galactosialidosis: a case report, BMC Rheumatology, 5, 1, 2021. Crossref

  38. Parolo Silvia, Tomasoni Danilo, Bora Pranami, Ramponi Alan, Kaddi Chanchala, Azer Karim, Domenici Enrico, Neves-Zaph Susana, Lombardo Rosario, Reconstruction of the Cytokine Signaling in Lysosomal Storage Diseases by Literature Mining and Network Analysis, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref

  39. Usenko Tatiana, Bezrukova Anastasia, Basharova Katerina, Panteleeva Alexandra, Nikolaev Mikhail, Kopytova Alena, Miliukhina Irina, Emelyanov Anton, Zakharova Ekaterina, Pchelina Sofya, Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic GBA Mutation Carriers and Patients with GBA-Associated Parkinson’s Disease, Genes, 12, 10, 2021. Crossref

  40. Ivanova Margarita, Limgala Renuka Pudi, Changsila Erk, Kamath Ravi, Ioanou Chidima, Goker-Alpan Ozlem, Gaucheromas: When macrophages promote tumor formation and dissemination, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  41. Cabrera-Reyes Fernanda, Parra-Ruiz Claudia, Yuseff María Isabel, Zanlungo Silvana, Alterations in Lysosome Homeostasis in Lipid-Related Disorders: Impact on Metabolic Tissues and Immune Cells, Frontiers in Cell and Developmental Biology, 9, 2021. Crossref

  42. Ivanova Margarita, Dao Julia, Noll Lauren, Fikry Jacqueline, Goker-Alpan Ozlem, TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease, Journal of Clinical Medicine, 10, 10, 2021. Crossref

  43. Zahran Asmaa M., Saad Khaled, Abdallah Alam-eldin M., Gad Eman F., Abdel-Raheem Yasser F., Zahran Zeinab Albadry M., Nagiub Abdelsalam Eman M., Elhoufey Amira, Alruwaili Thamer, Mahmoud Khaled Hashim, Elsayh Khalid I., Dendritic cells and monocyte subsets in children with Gaucher disease, Pediatric Research, 90, 3, 2021. Crossref

  44. Ishay Yuval, Zimran Ari, Szer Jeffrey, Dinur Tama, Ilan Yaron, Arkadir David, Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development, Blood Cells, Molecules, and Diseases, 68, 2018. Crossref

  45. Magnusen Albert Frank, Hatton Shelby Loraine, Rani Reena, Pandey Manoj Kumar, Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease, Frontiers in Neurology, 12, 2021. Crossref

  46. Magnusen Albert Frank, Rani Reena, McKay Mary Ashley, Hatton Shelby Loraine, Nyamajenjere Tsitsi Carol, Magnusen Daniel Nii Aryee, Köhl Jörg, Grabowski Gregory Alex, Pandey Manoj Kumar, C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease, International Journal of Molecular Sciences, 22, 23, 2021. Crossref

  47. Pandey Manoj Kumar, Jabre Nicholas A., Xu You-Hai, Zhang Wujuan, Setchell Kenneth D.R., Grabowski Gregory A., Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model, Molecular Genetics and Metabolism, 111, 2, 2014. Crossref

  48. Zahran Asmaa M., Saad Khaled, Elsayh Khalid I., Abdou Madleen Adel A., Abo-Elgheet Amir M., Eloseily Esraa M., Khalaf Shaimaa M., Sror Shabaan, Ahmad Faisal-Alkhateeb, Elhoufey Amira, Ghandour Aliaa, Osman Naglaa S., Upregulation of Cytotoxic T-cells in pediatric patients with Gaucher disease, Scientific Reports, 12, 1, 2022. Crossref

  49. Yañez M.J., Campos F., Marín T., Klein A.D., Futerman A.H., Alvarez A.R., Zanlungo S., c-Abl activates RIPK3 signaling in Gaucher disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1867, 5, 2021. Crossref

  50. Francelle Laetitia, Mazzulli Joseph R., Neuroinflammation in Gaucher disease, neuronal ceroid lipofuscinosis, and commonalities with Parkinson’s disease, Brain Research, 1780, 2022. Crossref

  51. Akiyama Tomohiko, Sato Saeko, Ko Shigeru B. H., Sano Osamu, Sato Sho, Saito Masayo, Nagai Hiroaki, Ko Minoru S. H., Iwata Hidehisa, Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells, Stem Cells Translational Medicine, 10, 4, 2021. Crossref

  52. Weinreb Neal J., Goker-Alpan Ozlem, Kishnani Priya S., Longo Nicola, Burrow T. Andrew, Bernat John A., Gupta Punita, Henderson Nadene, Pedro Helio, Prada Carlos E., Vats Divya, Pathak Ravi R., Wright Ekaterina, Ficicioglu Can, The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here?, Molecular Genetics and Metabolism, 136, 1, 2022. Crossref

  53. Hatton Shelby Loraine, Pandey Manoj Kumar, Fat and Protein Combat Triggers Immunological Weapons of Innate and Adaptive Immune Systems to Launch Neuroinflammation in Parkinson’s Disease, International Journal of Molecular Sciences, 23, 3, 2022. Crossref

  54. Roh Jaehyeok, Subramanian Subbaya, Weinreb Neal J., Kartha Reena V., Gaucher disease – more than just a rare lipid storage disease, Journal of Molecular Medicine, 100, 4, 2022. Crossref

  55. Kim Eun Na, Do Hyo‐Sang, Jeong Hwangkyo, Kim Taeho, Heo Sun Hee, Kim Yoo‐Mi, Cheon Chong Kun, Lee Yena, Choi Yunha, Choi In Hee, Choi Jeongmin, Yoo Han‐Wook, Kim Chong Jai, Zimran Ari, Kim Kyunggon, Lee Beom Hee, Identification of a novel therapeutic target underlying atypical manifestation of Gaucher disease, Clinical and Translational Medicine, 12, 5, 2022. Crossref

  56. Elstein Deborah, Zimran Ari, Gaucher Disease, in Lysosomal Storage Disorders, 2022. Crossref

  57. Bondar C., Mucci J., Crivaro A., Ormazabal M., Ceci R., Oliveri B., González D., Rozenfeld P., In vitro osteoclastogenesis from Gaucher patients' cells correlates with bone mineral density but not with Chitotriosidase, Bone, 103, 2017. Crossref

  58. Dupuis Lucie, Chauvet Margaux, Bourdelier Emmanuelle, Dussiot Michaël, Belmatoug Nadia, Le Van Kim Caroline, Chêne Arnaud, Franco Mélanie, Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells, International Journal of Molecular Sciences, 23, 14, 2022. Crossref

  59. Kido Jun, Nakamura Kimitoshi, Era Takumi, Role of induced pluripotent stem cells in lysosomal storage diseases, Molecular and Cellular Neuroscience, 108, 2020. Crossref

  60. Serratrice Christine, Bensalah Nesma, Penaranda Guillaume, Bardin Nathalie, Belmatoug Nadia, Masseau Agathe, Rose Christian, Lidove Olivier, Camou Fabrice, Maillot François, Leguy Vanessa, Magy-Bertrand Nadine, Marie Isabelle, Cherin Patrick, Bengherbia Monia, Carballo Sebastian, Boucraut José, Serratrice Jacques, Berger Marc, Verrot Denis, Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects, Joint Bone Spine, 85, 1, 2018. Crossref

  61. Sahasrabudhe Siddhee A., Terluk Marcia R., Rudser Kyle D., Cloyd James C., Kartha Reena V., Biological Variation in Peripheral Inflammation and Oxidative Stress Biomarkers in Individuals with Gaucher Disease, International Journal of Molecular Sciences, 23, 16, 2022. Crossref

  62. Zhang Zhenting, Wang Xiaohong, Lin Yi, Pan Dao, A multifaceted evaluation of microgliosis and differential cellular dysregulation of mammalian target of rapamycin signaling in neuronopathic Gaucher disease, Frontiers in Molecular Neuroscience, 15, 2022. Crossref

  63. Ivanova Margarita M., Dao Julia, Kasaci Neil, Friedman Andrew, Noll Lauren, Goker-Alpan Ozlem, Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease, Frontiers in Endocrinology, 13, 2022. Crossref

  64. Linari Silvia, Castaman Giancarlo, Hemostatic Abnormalities in Gaucher Disease: Mechanisms and Clinical Implications, Journal of Clinical Medicine, 11, 23, 2022. Crossref

  65. Trivedi Vyoma Snehal, Magnusen Albert Frank, Rani Reena, Marsili Luca, Slavotinek Anne Michele, Prows Daniel Ray, Hopkin Robert James, McKay Mary Ashley, Pandey Manoj Kumar, Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy, International Journal of Molecular Sciences, 23, 22, 2022. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain